International multi-center clinical trial of NM66603
Latest Information Update: 06 Nov 2023
At a glance
- Drugs NM 6603 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 06 Nov 2023 New trial record
Latest Information Update: 06 Nov 2023